AC Immune raises $43.5M

AC Immune S.A. (Lausanne, Switzerland) said it raised about $43.5 million in series E funding. Spokesperson Eva Schier declined to name the investors. The company is developing therapeutics and diagnostics for diseases caused by misfolded proteins and has three therapeutics in the clinic. ...